Revealdx
RevealDx develops RevealAI-Lung, computer-aided diagnostic software that analyzes radiomic features in chest CT scans and gives radiologists a malignancy similarity score for individual lung nodules. It aims to help clinicians identify which nodules need earlier follow-up and guide patients onto the right care pathway sooner.
Facts
- HQ
- Seattle, WA
- Sectors
- Healthcare, Medical Software, AI/ML, Radiology
- Founded
- 2022 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Precision Medical Ventures Inc Seattle business license
- Stage
- Seed
- Founders
- Michael Calhoun, PhD
Is this your organization? Claim it
RevealDx secures $3.4M from 4D Medical and global distribution for RevealAI-Lung across US, Europe, Australia, New Zealand
RevealDx raised $3.4 million from 4D Medical and struck a distribution agreement to have 4D Medical sell its RevealAI-Lung diagnostic software across the US, Europe, Australia, and New Zealand; the tool scores incidental lung nodules on CT using a Malignancy Similarity Index to guide radiologist follow-up. The software is validated on over 1,500 patients, holds CE, TGA and FDA clearances, and is reimbursable by Medicare under CPT codes 0721T and 0722T.
GeekWire 2026 Innovation of the Year Finalists Include Alpenglow Biosciences and Pacific Northwest National Laboratory
The 2026 GeekWire Awards announced finalists for Innovation of the Year, including Alpenglow Biosciences, Pacific Northwest National Laboratory, RevealDx, Starcloud, and VerAvanti, recognized for breakthroughs in healthcare and data center technology. The awards event will be held on May 7 in Seattle, with public voting open through April 10.
Seattle Startup RevealDx Raises $4.25M to Improve Lung Cancer Diagnosis with AI Technology
Seattle startup RevealDx raised $4.25 million to enhance lung cancer diagnosis using machine learning to analyze chest CT scans, aiming to accelerate diagnosis and reduce false positives. The company, formerly Mindshare Medical, is expanding in Europe and pursuing FDA approval in the U.S.
People
-
Chris Wood Executive, Chief Executive Officer
Online
Questions about Revealdx
What is Revealdx?
Revealdx is a startup based in Seattle, WA that develops RevealAI-Lung, computer-aided diagnostic software that analyzes chest CT scans and gives radiologists a malignancy similarity score for individual lung nodules.
What is Revealdx known for?
Revealdx is known for RevealAI-Lung’s use of radiomic features to help clinicians identify lung nodules that need earlier follow-up and guide patient care.
What has Revealdx been in the news for?
GeekWire reported in July 2024 on RevealDx's work to improve lung cancer diagnosis with AI technology.
Who are the people behind Revealdx?
Chris Wood is the chief executive officer of Revealdx.
Who invested in Revealdx, and how much has it raised?
Members of Seattle Flow see Revealdx's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Revealdx based?
Revealdx is based in Seattle, WA.